Earnings History Data for Cue Biopharma (CUE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cue Biopharma
Cue Biopharma, Inc. is an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. Cue Biopharma, Inc. is headquartered in Cambridge, Massachusetts.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
09-05-2024 | AH | CUE | Cue Biopharma | 106.00 | -0.25 | -0.30 | 0.00 | Cue Biopharma GAAP EPS of -$0.25 beats by $0.03, revenue of $1.7M beats by $0.49M [5/9/2024 6:04 PM] |
1.75 | -0.17 (-8.62%) |
0.0 | 0.0 (0.00%) |
1.30 - 5.12 | 433,922 | 420,000 | 0 | ||
08-08-2023 | AH | CUE | Cue Biopharma, Inc. | 154.58 | -0.29 | -0.30 | -0.37 | Cue Biopharma GAAP EPS of -$0.29 beats by $0.01, revenue of $1.38M beats by $0.47M [8/9/2023 4:50 PM] |
3.13 | -0.49 (-13.54%) |
0.0 | 0.0 (0.00%) |
2.18 - 5.12 | 1,196,099 | 340,000 | 0 | ||
14-11-2022 | AH | CUE | Cue Biopharma | 110.00 | -0.31 | -0.38 | 0.00 | Cue Biopharma GAAP EPS of -$0.31 beats by $0.07, revenue of $0.07M misses by $0.37M [11/14/2022 5:35 PM] |
3.88 | 0.62 (19.23%) |
3.30 | 0.05 (1.54%) |
2.18 - 18.42 | 369,048 | 170,000 | 2,134 | ||
10-05-2022 | AH | CUE | Cue Biopharma | 130.00 | -0.44 | -0.43 | 0.00 | Cue Biopharma GAAP EPS of -$0.44 misses by $0.02, revenue of $1M misses by $1.92M [5/10/2022 5:03 PM] |
3.54 | -0.65 (-15.60%) |
4.25 | 0.05 (1.19%) |
3.30 - 18.42 | 1,170,486 | 350,000 | 55,557 | ||
|
||||||||||||||||||
17-05-2021 | AH | CUE | Cue Biopharma, Inc. | 407.00 | -0.41 | -0.37 | 0.00 | Cue Biopharma EPS misses by $0.02, beats on revenue [5/17/2021 4:20 PM] |
13.46 | -0.54 (-3.86%) |
14.00 | 0.0 (0.00%) |
10.69 - 31.69 | 339,819 | 1,630,000 | 6,296 | ||
16-03-2021 | AH | 4:00 PM ET (Mar 16) |
CUE | Cue Biopharma, Inc. | 479.70 | -0.37 | -0.33 | -0.37 | Cue Biopharma EPS beats by $0.03, misses on revenue [3/16/2021 4:56 PM] |
13.95 | -0.87 (-5.87%) |
14.82 | 0.89 (6.39%) |
9.30 - 31.69 | 238,847 | 427,260 | 0 | |
|
||||||||||||||||||
17-11-2020 | AH | CUE | Cue Biopharma, Inc. | 361.00 | -0.34 | -0.37 | 0.00 | Cue Biopharma EPS beats by $0.12, misses on revenue [11/17/2020 4:07 PM] |
12.51 | 0.96 (8.31%) |
11.55 | 0.0 (0.00%) |
8.73 - 31.69 | 307,172 | 193,567 | 10,068 | ||
|
||||||||||||||||||
17-11-2020 | AH | CUE | Cue Biopharma, Inc. | 354.56 | -0.34 | -0.37 | -0.31 | Cue Biopharma EPS beats by $0.12, misses on revenue [11/17/2020 4:07 PM] |
12.22 | -0.48 (-3.78%) |
12.70 | 0.0 (0.00%) |
9.11 - 31.69 | 173,211 | 216,720 | 5,664 | ||